These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 4966856)
1. Vasoconstrictor and systemic activities of topical steroids. Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856 [No Abstract] [Full Text] [Related]
2. The psoriasis bio-assay for topical corticosteroid activity. Dumas KJ; Scholtz JR Acta Derm Venereol; 1972; 52(1):43-8. PubMed ID: 4111105 [No Abstract] [Full Text] [Related]
3. [Comparison of the efficiency of various externally used corticosteroids]. Horácek J; Semrádová V Z Hautkr; 1974 Jul; 49(13):555-8. PubMed ID: 4423320 [No Abstract] [Full Text] [Related]
5. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)]. Weirich EG; Lutz U Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215 [No Abstract] [Full Text] [Related]
6. Bioassay system for formulations of topically applied glucocorticosteroids. Stoughton RB Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246 [No Abstract] [Full Text] [Related]
7. [Practical importance and the criteria of value of external corticoids]. Weirich EG Wien Med Wochenschr; 1966 Aug; 116(32):665-73. PubMed ID: 5995274 [No Abstract] [Full Text] [Related]
8. A comparative study of topical corticosteroids. Nunis JB; Noojin RO South Med J; 1969 Jan; 62(1):30-2. PubMed ID: 4885737 [No Abstract] [Full Text] [Related]
9. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids. Poulsen BJ; Burdick K; Bessler S Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938 [No Abstract] [Full Text] [Related]
10. [Remarks on the percutaneous absorption of corticoids]. Rimbaud P; Meynadier J Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207 [No Abstract] [Full Text] [Related]
11. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial. Smith EB; Gregory JF; Bartruff JK South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656 [No Abstract] [Full Text] [Related]
12. Vasoconstrictor activity and percutaneous absorption of glucocorticosteroids. A direct comparison. Stoughton RB Arch Dermatol; 1969 Jun; 99(6):753-6. PubMed ID: 5814595 [No Abstract] [Full Text] [Related]
13. The evaluation of several topical corticosteroid preparations in the blanching test. Coldman MF; Lockerbie L; Laws EA Br J Dermatol; 1971 Oct; 85(4):381-7. PubMed ID: 5125641 [No Abstract] [Full Text] [Related]
15. Precise evaluation of topically applied corticosteroid potency. Modification of the Stoughton-McKenzie assay. Place VA; Velazquez JG; Burdick KH Arch Dermatol; 1970 May; 101(5):531-7. PubMed ID: 5444076 [No Abstract] [Full Text] [Related]
16. Topical corticosteroids--an experimental evaluation of the vasoconstrictor test as an index of anti-inflammatory activity. Reid J; Brookes DB Br J Dermatol; 1968 May; 80(5):328-36. PubMed ID: 4873078 [No Abstract] [Full Text] [Related]
17. Various vagaries of vasoconstriction. Burdick KH Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376 [No Abstract] [Full Text] [Related]
18. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test. Coldman MF; Lockerbie L; Laws EA Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552 [No Abstract] [Full Text] [Related]